NeuroXT and BIDMC Expand Collaboration to Advance AI-Driven Precision Treatment in Alzheimer's Disease

Building on successful research collaboration, the two organizations enter a new phase of their research to accelerate the progress towards clinical impact BOSTON, May 26, 2026 /PRNewswire/ -- NeuroXT, a leading biotechnology company specializing in AI-driven neuroimaging biomarkers,...